FINSX
Price
$50.20
Change
+$0.65 (+1.31%)
Updated
Aug 12 closing price
Net Assets
24.43B
RGEBX
Price
$81.45
Change
+$1.12 (+1.39%)
Updated
Aug 12 closing price
Net Assets
324.88B
Interact to see
Advertisement

FINSX vs RGEBX

Header iconFINSX vs RGEBX Comparison
Open Charts FINSX vs RGEBXBanner chart's image
Fidelity Advisor New Insights I
Price$50.20
Change+$0.65 (+1.31%)
VolumeN/A
Net Assets24.43B
American Funds Growth Fund of Amer R2E
Price$81.45
Change+$1.12 (+1.39%)
VolumeN/A
Net Assets324.88B
FINSX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FINSX vs. RGEBX commentary
Aug 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FINSX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 325B vs. FINSX (24.4B). FINSX pays higher dividends than RGEBX: FINSX (0.02) vs RGEBX (0.00). FINSX was incepted earlier than RGEBX: FINSX (22 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than FINSX (0.65). RGEBX is a more actively managed with annual turnover of: 25.00 vs. FINSX (18.00). FINSX has a lower initial minimum investment than RGEBX: FINSX (0) vs RGEBX (250). FINSX annual gain was more profitable for investors over the last year : 21.65 vs. RGEBX (18.71). RGEBX return over 5 years is better than : 40.58 vs. FINSX (37.21).
FINSXRGEBXFINSX / RGEBX
Total Expense Ratio0.651.0960%
Annual Report Gross Expense Ratio0.651.0960%
Fund Existence22 years11 years-
Gain YTD13.64714.01297%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets24.4B325B8%
Annual Yield % from dividends0.020.00-
Returns for 1 year21.6518.71116%
Returns for 3 years48.8340.73120%
Returns for 5 years37.2140.5892%
Returns for 10 years75.4280.2094%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTKB4.030.24
+6.33%
Cytek Biosciences
DXC13.260.41
+3.19%
DXC Technology Company
EUDA2.590.07
+2.78%
EUDA Health Holdings Limited
THC170.483.85
+2.31%
Tenet Healthcare Corp
ARTL9.72-0.31
-3.09%
Artelo Biosciences Inc